BIOLASE, Inc. is a medical device company that develops, manufactures, markets, and sells laser systems in dentistry and medicine and also markets, sells, and distributes dental imaging equipment. BIOLASE’s products are focused on better enabling clinicians to repair and restore patient’s dental conditions while reducing the pain, fear, and anxiety generally associated with dentistry. BIOLASE is committed to elevating the standard of care in dentistry, while enabling clinicians to achieve better business returns.

Company Growth (employees)
Type
Public
HQ
Irvine, US
Founded
1987
Size (employees)
225 (est)+13%
Biolase was founded in 1987 and is headquartered in Irvine, US

Key People/Management at Biolase

Jeffrey Nugent

Jeffrey Nugent

President and Chief Executive Officer
Dmitri Boutoussov

Dmitri Boutoussov

CTO
Frederick D. Furry

Frederick D. Furry

Chief Financial Officer
William E. Brown

William E. Brown

VP, Business Development

Biolase Office Locations

Biolase has offices in Irvine, Miami, Denver, Seattle and in 14 other locations
Irvine, US (HQ)
4 Cromwell
Show all (18)

Biolase Financials and Metrics

Biolase Financials

Biolase's revenue was reported to be $10.9 m in Q1, 2017
USD

Revenue (Q1, 2017)

10.9 m

Gross profit (Q1, 2017)

4 m

Gross profit margin (Q1, 2017), %

36%

Net income (Q1, 2017)

(4.1 m)

EBIT (Q1, 2017)

(4.1 m)

Market capitalization (20-Oct-2017)

46.1 m

Cash (31-Mar-2017)

3.6 m
Biolase's current market capitalization is $46.1 m.
USDFY, 2013FY, 2014FY, 2015FY, 2016

Revenue

56.4 m47.7 m48.5 m51.8 m

Revenue growth, %

(16%)2%7%

Cost of goods sold

34.9 m29.5 m32.5 m31.5 m

Gross profit

21.5 m18.2 m16 m20.3 m
USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017

Revenue

10.2 m12.7 m10.9 m11.9 m11.2 m11 m13.8 m13.2 m10.9 m

Cost of goods sold

6.5 m7.3 m7.6 m8.2 m7.9 m7.4 m8.2 m7.6 m6.9 m

Gross profit

3.7 m5.4 m3.2 m3.7 m3.4 m3.6 m5.7 m5.6 m4 m

Gross profit Margin, %

37%42%30%31%30%33%41%42%36%
USDFY, 2013FY, 2014FY, 2015FY, 2016

Cash

1.4 m31.6 m11.7 m8.9 m

Inventories

1.9 m1.7 m1.4 m13.5 m

Current Assets

25.9 m54.8 m34.8 m34 m

PP&E

1.8 m1.3 m3.7 m4.5 m
USDQ2, 2014Q3, 2014Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017

Cash

2.1 m2.8 m19.9 m15.2 m6.6 m4.9 m12.7 m3.6 m

Inventories

11.9 m11.8 m13.7 m14.1 m12.6 m11.3 m13.5 m14.7 m

Current Assets

21.4 m25.1 m45.2 m40.3 m31.1 m28.5 m37.3 m29.3 m

PP&E

1.6 m1.5 m2.4 m3.1 m3.8 m4 m3.9 m4.5 m
USDFY, 2013FY, 2014FY, 2015FY, 2016

Net Income

(11.5 m)(18.9 m)(20.3 m)(15.4 m)

Depreciation and Amortization

601 k696 k880 k1 m

Accounts Receivable

264 k826 k(52 k)(644 k)

Inventories

56 k(21 k)(65 k)(2 m)
USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017

Net Income

(11.3 m)(14.8 m)(5.4 m)(12.5 m)(17.8 m)(4.3 m)(7.8 m)(10.9 m)(4.1 m)

Depreciation and Amortization

352 k529 k158 k324 k589 k212 k488 k776 k290 k

Accounts Receivable

3.8 m1.1 m(860 k)(1 m)(500 k)(1.1 m)(2 m)(863 k)564 k

Inventories

(733 k)(682 k)(664 k)(1.2 m)(1.6 m)(1 k)908 k(1.4 m)(1.4 m)
USDY, 2017

Revenue/Employee

51.2 k

Financial Leverage

2 x
Show all financial metrics

Biolase Market Value History

Traffic Overview of Biolase

Biolase Online and Social Media Presence

Biolase Company Life and Culture

You may also be interested in